Home Data Calendar Blog

ALLO

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Common Stock Value		0.17	0.17	0.17	0.15	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14
Earnings Per Share Basic		-0.54	-0.37	-0.53	-0.68	-0.65	-0.58	-0.52	-0.56	-0.54	-0.57	-0.53	-0.25
Earnings Per Share Diluted		-0.54	-0.37	-0.53	-0.68	-0.65	-0.58	-0.52	-0.56	-0.54	-0.57	-0.53	-0.25

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenue From Contract With Customer Excluding Assessed Tax		-0.04	0.04	0.04	0.05	0.05	0.05	0.09	0.06	0.05	0.05	0.04	38.34
Revenues		-0.04	0.04	0.04	0.05	0.05	0.05	0.09	0.06	0.05	0.05	0.04	38.34
Operating Expenses		85.13	63.02	80.56	99.12	96.42	82.54	76.68	80.05	73.94	77.72	71.07	71.55
Research And Development Expense		54.66	45.98	62.04	80.24	75.42	63.64	57.17	60.16	53.98	58.72	52.29	55.18
General And Administrative Expense		17.22	17.04	18.52	18.88	21.00	18.90	19.51	19.90	19.96	19.00	18.78	16.36
Operating Income Loss		-85.17	-62.98	-80.52	-99.07	-96.37	-82.49	-76.59	-79.99	-73.89	-77.67	-71.03	-33.20
Allocated Share Based Compensation Expense		15.28	15.35	16.59	18.77	17.25	21.15	22.89	22.32	22.04	20.86	21.13	16.79
Profit Loss		-89.26	-61.31	-77.99	-98.70	-94.85	-83.15	-74.79	-79.85	-74.87	-78.19	-70.94	-33.02
Net Income Loss		-89.26	-61.31	-77.99	-98.70	-94.85	-83.15	-74.79	-79.85	-74.87	-78.19	-70.94	-33.02
Comprehensive Income Net Of Tax		-87.80	-59.88	-75.91	-94.71	-91.81	-84.63	-77.01	-86.53	-77.04	-78.25	-71.17	-33.38

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets		642.84	712.33	770.97	746.87	817.08	887.57	947.64	964.63	1038.63	1079.25	1126.72	1179.04
Liabilities		130.60	129.22	148.06	154.61	151.21	147.61	145.69	109.40	122.23	109.30	102.91	109.27
Liabilities And Stockholders Equity		642.84	712.33	770.97	746.87	817.08	887.57	947.64	964.63	1038.63	1079.25	1126.72	1179.04
Stockholders Equity		512.23	583.10	622.91	592.26	665.87	739.96	801.95	855.23	916.41	969.94	1023.81	1069.78

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets Current		459.12	473.45	502.10	481.46	528.82	569.06	513.03	469.74	471.32	502.86	602.17	716.06
Cash And Cash Equivalents At Carrying Value		83.16	69.25	154.76	109.93	61.90	74.36	96.04	84.51	173.31	190.02	223.50	236.87
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		93.45	79.54	165.05	120.22	72.20	84.65	106.33	94.81	183.61	199.47	232.95	246.31
Prepaid Expense And Other Assets Current		10.42	7.95	10.14	10.24	11.50	16.83	22.54	20.69	14.02	19.37	14.46	16.48
Available For Sale Securities Debt Securities		444.08	NA	NA	NA	526.33	582.21	NA	NA	752.03	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Property Plant And Equipment Gross		150.56	150.43	150.42	150.24	149.72	149.03	147.94	147.25	146.35	145.00	142.25	137.97
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		51.08	47.61	44.03	40.39	36.88	34.59	30.73	27.05	23.36	19.12	16.79	14.82
Property Plant And Equipment Net		99.48	102.83	106.39	109.85	112.84	114.44	117.22	120.20	122.99	125.88	125.46	123.15
Investments In Affiliates Subsidiaries Associates And Joint Ventures		3.65	5.37	9.91	11.12	12.82	14.05	15.70	14.20	18.00	17.91	18.82	19.35
Other Assets Noncurrent		6.60	9.58	9.38	9.39	9.56	9.38	8.94	9.04	5.82	6.16	5.83	6.28
Available For Sale Debt Securities Amortized Cost Basis		444.59	491.31	541.59	512.88	535.81	594.72	633.96	692.75	754.16	806.45	859.35	903.58

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Liabilities Current		37.08	37.64	54.72	59.59	54.52	48.87	44.91	36.88	48.17	53.49	46.00	54.85
Accounts Payable Current		5.90	6.21	10.23	14.69	13.89	11.04	9.71	8.71	10.26	11.50	11.01	14.88
Other Liabilities Current		1.81	NA	NA	NA	2.12	NA	NA	NA	4.95	NA	NA	NA
Contract With Customer Liability Current		0.09	0.24	0.23	0.27	0.89	0.89	0.84	0.41	0.42	0.36	0.30	0.24

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Other Liabilities Noncurrent		5.18	1.49	1.52	1.51	1.57	2.03	2.55	3.49	4.12	5.17	5.71	2.79
Operating Lease Liability Noncurrent		88.35	90.10	91.82	93.51	95.12	96.71	98.23	69.03	69.93	50.64	51.21	51.62

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Stockholders Equity		512.23	583.10	622.91	592.26	665.87	739.96	801.95	855.23	916.41	969.94	1023.81	1069.78
Common Stock Value		0.17	0.17	0.17	0.15	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14
Additional Paid In Capital Common Stock		2075.25	2059.33	2039.26	1932.73	1911.63	1893.91	1871.26	1847.53	1822.18	1798.68	1774.30	1749.10
Retained Earnings Accumulated Deficit		-1562.23	-1473.99	-1412.67	-1334.68	-1235.98	-1141.13	-1057.98	-983.20	-903.35	-828.48	-750.29	-679.36
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.95	-2.41	-3.85	-5.93	-9.93	-12.96	-11.47	-9.25	-2.57	-0.40	-0.33	-0.10

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities		-53.71	-55.53	-61.86	-66.64	-62.10	-47.66	-42.53	-68.24	-45.44	-48.88	-41.17	-49.33
Net Cash Provided By Used In Investing Activities		67.46	-34.27	17.16	112.94	49.60	24.91	54.03	-22.38	29.25	13.01	24.59	96.80
Net Cash Provided By Used In Financing Activities		0.15	4.29	89.52	1.73	0.05	1.07	0.02	1.81	0.32	2.38	3.21	6.04

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities		-53.71	-55.53	-61.86	-66.64	-62.10	-47.66	-42.53	-68.24	-45.44	-48.88	-41.17	-49.33
Net Income Loss		-89.26	-61.31	-77.99	-98.70	-94.85	-83.15	-74.79	-79.85	-74.87	-78.19	-70.94	-33.02
Profit Loss		-89.26	-61.31	-77.99	-98.70	-94.85	-83.15	-74.79	-79.85	-74.87	-78.19	-70.94	-33.02
Increase Decrease In Accounts Payable		-0.30	-3.97	-4.29	1.06	2.94	1.01	1.42	-0.51	-2.04	0.19	-3.06	4.15
Share Based Compensation		15.23	15.35	16.59	18.77	17.25	21.15	22.89	22.32	22.04	20.86	21.13	16.79

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Investing Activities		67.46	-34.27	17.16	112.94	49.60	24.91	54.03	-22.38	29.25	13.01	24.59	96.80
Payments To Acquire Property Plant And Equipment		0.18	0.01	0.29	1.03	1.69	0.22	1.37	1.90	0.74	3.35	10.90	6.46
Payments To Acquire Investments		68.70	199.41	135.42	35.09	47.79	49.45	61.71	89.16	50.78	145.42	180.33	149.05

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Financing Activities		0.15	4.29	89.52	1.73	0.05	1.07	0.02	1.81	0.32	2.38	3.21	6.04

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenues		-0.04	0.04	0.04	0.05	0.05	0.05	0.09	0.06	0.05	0.05	0.04	38.34
Allogene Overland Allogene Overland Bio Pharm H K Limited		0.00	0.10	0.10	0.10	0.00	0.10	0.10	0.10	0.10	0.10	0.10	38.30
Revenue From Contract With Customer Excluding Assessed Tax		-0.04	0.04	0.04	0.05	0.05	0.05	0.09	0.06	0.05	0.05	0.04	38.34
Allogene Overland Allogene Overland Bio Pharm H K Limited		0.00	0.10	0.10	0.10	0.00	0.10	0.10	0.10	0.10	0.10	0.10	38.30

Plots across concepts

Line plots across dimensions of each concept